Publication Information

{'id': 'https://openalex.org/W2014709373', 'doi': 'https://doi.org/10.1002/art.22331', 'title': 'Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study', 'display_name': 'Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study', 'publication_year': 2006, 'publication_date': '2006-12-28', 'ids': {'openalex': 'https://openalex.org/W2014709373', 'doi': 'https://doi.org/10.1002/art.22331', 'mag': '2014709373', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17195186'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/art.22331', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S132787887', 'display_name': 'Arthritis & Rheumatism', 'issn_l': '0004-3591', 'issn': ['0004-3591', '1529-0131'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': 'https://doi.org/10.1002/art.22331', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5036981821', 'display_name': 'Kimme L Hyrich', 'orcid': 'https://orcid.org/0000-0001-8242-9262'}, 'institutions': [{'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Kimme L. Hyrich', 'raw_affiliation_strings': ['University\xa0of\xa0Manchester, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'University\xa0of\xa0Manchester, Manchester, UK', 'institution_ids': ['https://openalex.org/I28407311']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047692275', 'display_name': 'Mark Lunt', 'orcid': 'https://orcid.org/0000-0002-2391-5575'}, 'institutions': [{'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Mark Lunt', 'raw_affiliation_strings': ['University\xa0of\xa0Manchester, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'University\xa0of\xa0Manchester, Manchester, UK', 'institution_ids': ['https://openalex.org/I28407311']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110222516', 'display_name': 'Kath Watson', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Kath D. Watson', 'raw_affiliation_strings': ['University\xa0of\xa0Manchester, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'University\xa0of\xa0Manchester, Manchester, UK', 'institution_ids': ['https://openalex.org/I28407311']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027951754', 'display_name': 'Deborah Symmons', 'orcid': 'https://orcid.org/0000-0002-8625-1200'}, 'institutions': [{'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Deborah P. M. Symmons', 'raw_affiliation_strings': ['University\xa0of\xa0Manchester, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'University\xa0of\xa0Manchester, Manchester, UK', 'institution_ids': ['https://openalex.org/I28407311']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5018096937', 'display_name': 'Alan J. Silman', 'orcid': 'https://orcid.org/0000-0001-8426-8925'}, 'institutions': [{'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Alan J. Silman', 'raw_affiliation_strings': ['University\xa0of\xa0Manchester, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'University\xa0of\xa0Manchester, Manchester, UK', 'institution_ids': ['https://openalex.org/I28407311']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 23.3, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 401, 'citation_normalized_percentile': {'value': 0.957534, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '56', 'issue': '1', 'first_page': '13', 'last_page': '20'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9974, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/discontinuation', 'display_name': 'Discontinuation', 'score': 0.7981714}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.86947}, {'id': 'https://openalex.org/C2778715236', 'wikidata': 'https://www.wikidata.org/wiki/Q55622662', 'display_name': 'Discontinuation', 'level': 2, 'score': 0.7981714}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.75467813}, {'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.6375471}, {'id': 'https://openalex.org/C2777226972', 'wikidata': 'https://www.wikidata.org/wiki/Q415343', 'display_name': 'Etanercept', 'level': 3, 'score': 0.6241226}, {'id': 'https://openalex.org/C207103383', 'wikidata': 'https://www.wikidata.org/wiki/Q3930246', 'display_name': 'Hazard ratio', 'level': 3, 'score': 0.5880466}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.577241}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.45200628}, {'id': 'https://openalex.org/C2777138892', 'wikidata': 'https://www.wikidata.org/wiki/Q415264', 'display_name': 'Infliximab', 'level': 3, 'score': 0.4495557}, {'id': 'https://openalex.org/C72563966', 'wikidata': 'https://www.wikidata.org/wiki/Q1303415', 'display_name': 'Cohort', 'level': 2, 'score': 0.43947366}, {'id': 'https://openalex.org/C29730261', 'wikidata': 'https://www.wikidata.org/wiki/Q274160', 'display_name': 'Toxicity', 'level': 2, 'score': 0.4235344}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.38391668}, {'id': 'https://openalex.org/C44249647', 'wikidata': 'https://www.wikidata.org/wiki/Q208498', 'display_name': 'Confidence interval', 'level': 2, 'score': 0.3601523}], 'mesh': [{'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D000206', 'descriptor_name': 'Actuarial Analysis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068879', 'descriptor_name': 'Adalimumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': False}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015331', 'descriptor_name': 'Cohort Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068800', 'descriptor_name': 'Etanercept', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069285', 'descriptor_name': 'Infliximab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016016', 'descriptor_name': 'Proportional Hazards Models', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011446', 'descriptor_name': 'Prospective Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D019233', 'descriptor_name': 'Retreatment', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017211', 'descriptor_name': 'Treatment Failure', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006113', 'descriptor_name': 'United Kingdom', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/art.22331', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S132787887', 'display_name': 'Arthritis & Rheumatism', 'issn_l': '0004-3591', 'issn': ['0004-3591', '1529-0131'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17195186', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/art.22331', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S132787887', 'display_name': 'Arthritis & Rheumatism', 'issn_l': '0004-3591', 'issn': ['0004-3591', '1529-0131'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.79, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 34, 'referenced_works': ['https://openalex.org/W1809006196', 'https://openalex.org/W1840538016', 'https://openalex.org/W1877964961', 'https://openalex.org/W1974956454', 'https://openalex.org/W1977078113', 'https://openalex.org/W1979364075', 'https://openalex.org/W1985763670', 'https://openalex.org/W1996472975', 'https://openalex.org/W2018600081', 'https://openalex.org/W2032586021', 'https://openalex.org/W2036047236', 'https://openalex.org/W2039597867', 'https://openalex.org/W2045485006', 'https://openalex.org/W2048802582', 'https://openalex.org/W2066176190', 'https://openalex.org/W2086721113', 'https://openalex.org/W2098767548', 'https://openalex.org/W2110177517', 'https://openalex.org/W2112966993', 'https://openalex.org/W2116033495', 'https://openalex.org/W2116843833', 'https://openalex.org/W2122265491', 'https://openalex.org/W2129841863', 'https://openalex.org/W2129867349', 'https://openalex.org/W2133028044', 'https://openalex.org/W2152245204', 'https://openalex.org/W2155222784', 'https://openalex.org/W2161159725', 'https://openalex.org/W2162716725', 'https://openalex.org/W2163624896', 'https://openalex.org/W2252829258', 'https://openalex.org/W2314052274', 'https://openalex.org/W2413043776', 'https://openalex.org/W2460286564'], 'related_works': ['https://openalex.org/W3149869290', 'https://openalex.org/W2980843199', 'https://openalex.org/W2809810071', 'https://openalex.org/W2755604283', 'https://openalex.org/W2318799791', 'https://openalex.org/W2236197927', 'https://openalex.org/W2162495586', 'https://openalex.org/W2116752853', 'https://openalex.org/W2075153701', 'https://openalex.org/W1588288904'], 'abstract_inverted_index': {'Patients': [0], 'with': [1, 9, 189, 227, 308], 'rheumatoid': [2], 'arthritis': [3], '(RA)': [4], 'who': [5, 164, 252, 268], 'experience': [6], 'treatment': [7, 73], 'failure': [8], 'one': [10], 'anti-tumor': [11], 'necrosis': [12], 'factor': [13], '(anti-TNF)': [14], 'agent,': [15, 29], 'due': [16, 102, 111, 184, 197, 222, 235], 'to': [17, 25, 42, 103, 112, 122, 132, 144, 166, 185, 198, 223, 236, 255, 281], 'either': [18], 'inefficacy': [19, 104, 186, 199, 245], 'or': [20, 159], 'toxicity,': [21, 113], 'are': [22, 35, 253, 279], 'frequently': [23], 'switched': [24, 121, 165, 254], 'a': [26, 59, 66, 89, 123, 167, 256, 276], 'second': [27, 52, 124, 168, 194, 232, 257, 277], 'anti-TNF': [28, 55, 72, 125, 169, 258], 'although': [30, 265], 'the': [31, 48, 99, 108, 149, 154, 173, 177, 272, 282, 286, 294, 297, 301], 'benefits': [32], 'of': [33, 54, 62, 70, 93, 114, 151, 162, 179, 193, 231, 263, 300, 303], 'switching': [34], 'unknown.': [36], 'The': [37], 'present': [38], 'study': [39, 57], 'was': [40, 142, 187, 225], 'undertaken': [41], 'compare': [43, 145], 'drug': [44, 101, 110, 182, 195, 220, 233, 259, 278], 'continuation': [45, 134], 'rates': [46, 135, 262], 'between': [47], 'first': [49, 100, 109, 219, 287, 298], 'course': [50, 53, 147], 'and': [51, 84, 105, 117, 139, 153], 'therapy.The': [56], 'involved': [58], 'prospective': [60], 'cohort': [61], 'RA': [63], 'patients': [64, 96, 163, 251, 307], 'from': [65, 293], 'UK': [67, 295], 'national': [68], 'register': [69], 'new': [71, 174], 'starts': [74], '(n': [75], '=': [76], '6,739;': [77], '876': [78], 'starting': [79, 82, 85], 'adalimumab,': [80], '2,826': [81], 'etanercept,': [83], '3,037': [86], 'infliximab).': [87], 'Over': [88], 'mean': [90], '15': [91], 'months': [92], 'followup,': [94], '841': [95], 'stopped': [97, 107], 'taking': [98], '1,023': [106], 'whom': [115], '503': [116], '353,': [118], 'respectively,': [119], 'were': [120, 130], 'agent.': [126], 'Kaplan-Meier': [127], 'survival': [128], 'curves': [129], 'plotted': [131], 'determine': [133], 'for': [136, 148, 156, 274, 284], 'each': [137, 146], 'course,': [138], 'Cox': [140], 'regression': [141], 'used': [143], 'risk': [150], 'stopping': [152, 157, 275, 285], 'reason': [155], '(inefficacy': [158], 'toxicity).Overall,': [160], '73%': [161], 'agent': [170], 'remained': [171], 'on': [172], 'therapy': [175], 'by': [176], 'end': [178], 'followup.': [180], 'First': [181], 'discontinuation': [183, 196, 221, 234], 'associated': [188, 226], 'an': [190, 228], 'increased': [191, 229], 'rate': [192, 230], '(hazard': [200], 'ratio': [201], '[HR]': [202], '2.7,': [203], '95%': [204, 215, 240, 248], 'confidence': [205], 'interval': [206], '[95%': [207], 'CI]': [208], '2.1-3.4)': [209], 'but': [210, 243], 'not': [211, 244], 'toxicity': [212, 224, 237], '(HR': [213, 238, 246], '1.1,': [214], 'CI': [216, 241, 249], '0.9-1.5).': [217], 'Similarly,': [218], '2.3,': [239], '1.9-2.9)': [242], '1.2,': [247], '0.8-1.6).RA': [250], 'have': [260], 'high': [261], 'continuation,': [264], 'among': [266], 'those': [267], 'must': [269], 'discontinue': [270], 'treatment,': [271], 'reasons': [273, 283], 'related': [280], 'drug.': [288], 'This': [289], 'large': [290], 'data': [291], 'set': [292], 'provides': [296], 'estimates': [299], 'magnitude': [302], 'these': [304], 'effects': [305], 'in': [306], 'long-standing': [309], 'severe': [310], 'RA.': [311]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2014709373', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 6}, {'year': 2022, 'cited_by_count': 7}, {'year': 2021, 'cited_by_count': 5}, {'year': 2020, 'cited_by_count': 12}, {'year': 2019, 'cited_by_count': 11}, {'year': 2018, 'cited_by_count': 13}, {'year': 2017, 'cited_by_count': 25}, {'year': 2016, 'cited_by_count': 24}, {'year': 2015, 'cited_by_count': 18}, {'year': 2014, 'cited_by_count': 37}, {'year': 2013, 'cited_by_count': 18}, {'year': 2012, 'cited_by_count': 33}], 'updated_date': '2024-12-09T03:29:21.570900', 'created_date': '2016-06-24'}